Evolent Health’s Registered Secondary Common Stock Offering
June 28, 2017
Cravath represented Evolent Health, Inc. in connection with its US$116 million registered secondary common stock offering. Evolent Health partners with leading provider organizations to achieve superior clinical and financial results in value‑based care. The shares were listed on the New York Stock Exchange. The transaction closed on June 28, 2017.
The Cravath team included partner William V. Fogg, practice area attorney Elizabeth A. Morgan and associates Ryan M. Farha, Erim E. Tuc, and Cole‑Gabriel DuMond.
Related Practices & Industries
People
- Photo
-
-
J.D., 1991, Columbia Law SchoolHarlan Fiske Stone Scholar
-
A.B., 1988, Brown Universitymagna cum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
June 17, 2024
Community Health Systems, Inc.’s $1.225 Billion High‑Yield Senior Secured Notes Offering
Cravath represented the initial purchasers in connection with the $1.225 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. The transaction closed on June 5, 2024.
Deals & Cases
January 24, 2024
Community Health Systems, Inc.’s $1 Billion High‑Yield Senior Secured Notes Offering and Concurrent Cash Tender Offer
Cravath represented the initial purchasers in connection with the $1 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. Cravath also represented the dealer manager in connection with the concurrent $985 million cash tender offer. The high‑yield senior secured notes offering closed on December 22, 2023, and the cash tender offer closed on January 10, 2024.
